Skip to main content
Erschienen in: Current Infectious Disease Reports 9/2016

01.09.2016 | Sepsis and ICU (JL Vincent, Section Editor)

Differential Paradigms in Animal Models of Sepsis

verfasst von: S. Manoj Kumar Kingsley, B. Vishnu Bhat

Erschienen in: Current Infectious Disease Reports | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Sepsis is a serious clinical problem involving complex mechanisms which requires better understanding and insight. Animal models of sepsis have played a major role in providing insight into the complex pathophysiology of sepsis. There have been various animal models of sepsis with different paradigms. Endotoxin, bacterial infusion, cecal ligation and puncture, and colon ascendens stent peritonitis models are the commonly practiced methods at present. Each of these models has their own advantages and also confounding factors. We have discussed the underlying mechanisms regulating each of these models along with possible reasons why each model failed to translate into the clinic. In animal models, the timing of development of the hemodynamic phases and the varied cytokine patterns could not accurately resemble the progression of clinical sepsis. More often, the exuberant and transient pro-inflammatory cytokine response is only focused in most models. Immunosuppression and apoptosis in the later phase of sepsis have been found to cause more damage than the initial acute phase of sepsis. Likewise, better understanding of the existing models of sepsis could help us create a more relevant model which could provide solution to the currently failed clinical trials in sepsis.
Literatur
1.
Zurück zum Zitat Seok J, Warren S, Cuenca A, Mindrinos M, Baker H, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110:3507–12.PubMedPubMedCentralCrossRef Seok J, Warren S, Cuenca A, Mindrinos M, Baker H, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110:3507–12.PubMedPubMedCentralCrossRef
2.••
Zurück zum Zitat Takao K, Miyakawa T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2015;112:1167–72. This study showed that gene expression patterns in mouse models closely resembled those in human inflammatory conditions and emphasised the use of mice as animal models of human inflammatory disorders. PubMedCrossRef Takao K, Miyakawa T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2015;112:1167–72. This study showed that gene expression patterns in mouse models closely resembled those in human inflammatory conditions and emphasised the use of mice as animal models of human inflammatory disorders. PubMedCrossRef
4.
Zurück zum Zitat Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 2005;4:854–65.PubMedCrossRef Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 2005;4:854–65.PubMedCrossRef
5.
Zurück zum Zitat Groeneveld AB, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery. 1986;99:140–53.PubMed Groeneveld AB, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery. 1986;99:140–53.PubMed
6.
Zurück zum Zitat Abraham E, Shoemaker WC, Bland RD, Cobo JC. Sequential cardiorespiratory patterns in septic shock. Crit Care Med. 1983;11:799–803.PubMedCrossRef Abraham E, Shoemaker WC, Bland RD, Cobo JC. Sequential cardiorespiratory patterns in septic shock. Crit Care Med. 1983;11:799–803.PubMedCrossRef
7.
Zurück zum Zitat Esmon CT. Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med. 2004;32:S219–22.PubMedCrossRef Esmon CT. Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med. 2004;32:S219–22.PubMedCrossRef
8.
Zurück zum Zitat Poll VT der, Deventer S. Endotoxemia in healthy subjects as a human model of inflammation. Immune Response in the Critically Ill. 2002: 335–357. Poll VT der, Deventer S. Endotoxemia in healthy subjects as a human model of inflammation. Immune Response in the Critically Ill. 2002: 335–357.
9.
Zurück zum Zitat Deventer VS, Buller HR, Cate TJ, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 1990;76:2520–6.PubMed Deventer VS, Buller HR, Cate TJ, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 1990;76:2520–6.PubMed
10.
11.
Zurück zum Zitat Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol. 1995;155:5038–45.PubMed Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol. 1995;155:5038–45.PubMed
12.
Zurück zum Zitat Martich GD, Parker MM, Cunnion RE, Suffredini AF. Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol. 1992;73:925–31.PubMed Martich GD, Parker MM, Cunnion RE, Suffredini AF. Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol. 1992;73:925–31.PubMed
13.
Zurück zum Zitat Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 1989;320:1165–72.PubMedCrossRef Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 1989;320:1165–72.PubMedCrossRef
14.•
Zurück zum Zitat Remick DG, Newcomb DE, Bolgos GL, Call DR. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock. 2000;13:110–6. This study showed the superiority of the CLP model of sepsis to that of the LPS model. LPS model of sepsis induced an acute and transient rise of pro-inflammatory cytokines which declined soon, whereas the CLP model showed a gradual and prolonged elevation of inflammatory cytokines that resembles human sepsis. PubMedCrossRef Remick DG, Newcomb DE, Bolgos GL, Call DR. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock. 2000;13:110–6. This study showed the superiority of the CLP model of sepsis to that of the LPS model. LPS model of sepsis induced an acute and transient rise of pro-inflammatory cytokines which declined soon, whereas the CLP model showed a gradual and prolonged elevation of inflammatory cytokines that resembles human sepsis. PubMedCrossRef
15.
Zurück zum Zitat Michie HR, Manogue KR, Spriggs DR, Revhaug A, O’Dwyer S, Dinarello CA, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481–6.PubMedCrossRef Michie HR, Manogue KR, Spriggs DR, Revhaug A, O’Dwyer S, Dinarello CA, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481–6.PubMedCrossRef
16.
Zurück zum Zitat Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990;161:79–84.PubMedCrossRef Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990;161:79–84.PubMedCrossRef
17.
18.
Zurück zum Zitat Kellum J, Kong L, Fink M, Weissfeld L, Yealy D, Pinsky M, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med. 2007;167:1655–63.PubMedPubMedCentralCrossRef Kellum J, Kong L, Fink M, Weissfeld L, Yealy D, Pinsky M, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med. 2007;167:1655–63.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Remick DG, Ward PA. Evaluation of endotoxin models for the study of sepsis. Shock. 2005;24 Suppl 1:7–11.PubMedCrossRef Remick DG, Ward PA. Evaluation of endotoxin models for the study of sepsis. Shock. 2005;24 Suppl 1:7–11.PubMedCrossRef
20.
Zurück zum Zitat Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, et al. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol. 2011;31:379–446.PubMedCrossRef Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, et al. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol. 2011;31:379–446.PubMedCrossRef
21.
Zurück zum Zitat Yamamoto M, Akira S. Lipid A receptor TLR4-mediated signaling pathways. Adv Exp Med Biol. 2010;667:59–68.PubMedCrossRef Yamamoto M, Akira S. Lipid A receptor TLR4-mediated signaling pathways. Adv Exp Med Biol. 2010;667:59–68.PubMedCrossRef
22.
Zurück zum Zitat Engelhardt R, Mackensen A, Galanos C. Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res. 1991;51:2524–30.PubMed Engelhardt R, Mackensen A, Galanos C. Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res. 1991;51:2524–30.PubMed
23.
Zurück zum Zitat Engelhardt R, Mackensen A, Galanos C, Andreesen R. Biological response to intravenously administered endotoxin in patients with advanced cancer. J Biol Response Mod. 1990;9:480–91.PubMed Engelhardt R, Mackensen A, Galanos C, Andreesen R. Biological response to intravenously administered endotoxin in patients with advanced cancer. J Biol Response Mod. 1990;9:480–91.PubMed
24.
Zurück zum Zitat Richardson RP, Rhyne CD, Fong Y, Hesse DG, Tracey KJ, Marano MA, et al. Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. Ann Surg. 1989;210:239–45.PubMedPubMedCentralCrossRef Richardson RP, Rhyne CD, Fong Y, Hesse DG, Tracey KJ, Marano MA, et al. Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. Ann Surg. 1989;210:239–45.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Reynolds K, Novosad B, Hoffhines A, Gipson J, Johnson J, Peters J, et al. Pretreatment with troglitazone decreases lethality during endotoxemia in mice. J Endotoxin Res. 2002;8:307–14.PubMedCrossRef Reynolds K, Novosad B, Hoffhines A, Gipson J, Johnson J, Peters J, et al. Pretreatment with troglitazone decreases lethality during endotoxemia in mice. J Endotoxin Res. 2002;8:307–14.PubMedCrossRef
27.
Zurück zum Zitat Fink MP, Morrissey PE, Stein KL, Clement RE, Fiallo V, Gardiner WM. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits. Circ Shock. 1988;26:41–57.PubMed Fink MP, Morrissey PE, Stein KL, Clement RE, Fiallo V, Gardiner WM. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits. Circ Shock. 1988;26:41–57.PubMed
28.
Zurück zum Zitat Johnston TD, Hampton WW, Fry DE. Septic hemodynamics produced by infusion of endotoxin. Curr Surg. 1989;46:101–3.PubMed Johnston TD, Hampton WW, Fry DE. Septic hemodynamics produced by infusion of endotoxin. Curr Surg. 1989;46:101–3.PubMed
29.
Zurück zum Zitat Talke P, Dunn A, Lawlis L, Sziebert L, White A, Herndon D, et al. A model of ovine endotoxemia characterized by an increased cardiac output. Circ Shock. 1985;17:103–8.PubMed Talke P, Dunn A, Lawlis L, Sziebert L, White A, Herndon D, et al. A model of ovine endotoxemia characterized by an increased cardiac output. Circ Shock. 1985;17:103–8.PubMed
30.
Zurück zum Zitat Sugi K, Newald J, Traber LD. Cardiac dysfunction after acute endotoxin administration in conscious sheep. Am J Physiol. 1991;260:H1474–81.PubMed Sugi K, Newald J, Traber LD. Cardiac dysfunction after acute endotoxin administration in conscious sheep. Am J Physiol. 1991;260:H1474–81.PubMed
31.
Zurück zum Zitat Lindsey DC, Jr ET, Thompson TE, John AE, Duerr ML, Valdez CM, et al. Characterization of an endotoxemic baboon model of metabolic and organ dysfunction. Circ Shock. 1991;34:298–310.PubMed Lindsey DC, Jr ET, Thompson TE, John AE, Duerr ML, Valdez CM, et al. Characterization of an endotoxemic baboon model of metabolic and organ dysfunction. Circ Shock. 1991;34:298–310.PubMed
32.
Zurück zum Zitat Wyler F, Neutze JM, Rudolph AM. Effects of endotoxin on distribution of cardiac output in unanesthetized rabbits. Am J Physiol. 1970;219:246–51.PubMed Wyler F, Neutze JM, Rudolph AM. Effects of endotoxin on distribution of cardiac output in unanesthetized rabbits. Am J Physiol. 1970;219:246–51.PubMed
33.
Zurück zum Zitat Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF, et al. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock. 1985;17:273–84.PubMed Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF, et al. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock. 1985;17:273–84.PubMed
34.
Zurück zum Zitat Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med. 1993;328:1457–60.PubMedCrossRef Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med. 1993;328:1457–60.PubMedCrossRef
35.
Zurück zum Zitat Traber DL, Redl H, Schlag G, Herndon DN, Kimura R, Prien T, et al. Cardiopulmonary responses to continuous administration of endotoxin. Am J Physiol. 1988;254:H833–9.PubMed Traber DL, Redl H, Schlag G, Herndon DN, Kimura R, Prien T, et al. Cardiopulmonary responses to continuous administration of endotoxin. Am J Physiol. 1988;254:H833–9.PubMed
36.
Zurück zum Zitat Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res. 1990;49:186–96.PubMedCrossRef Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res. 1990;49:186–96.PubMedCrossRef
37.
Zurück zum Zitat van der Poll T. Preclinical sepsis models. Surg Infect. 2012;13:287–92.CrossRef van der Poll T. Preclinical sepsis models. Surg Infect. 2012;13:287–92.CrossRef
38.
Zurück zum Zitat Fink MP, Fiallo V, Stein KL, Gardiner WM. Systemic and regional hemodynamic changes after intraperitoneal endotoxin in rabbits: development of a new model of the clinical syndrome of hyperdynamic sepsis. Circ Shock. 1987;22:73–81.PubMed Fink MP, Fiallo V, Stein KL, Gardiner WM. Systemic and regional hemodynamic changes after intraperitoneal endotoxin in rabbits: development of a new model of the clinical syndrome of hyperdynamic sepsis. Circ Shock. 1987;22:73–81.PubMed
39.
Zurück zum Zitat Takashima, Matsunaga, Yoshimatsu, Hazeki, Kaisho, Uekata, et al. Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model. Br J Pharmacol. 2009;157:1250–62.PubMedPubMedCentralCrossRef Takashima, Matsunaga, Yoshimatsu, Hazeki, Kaisho, Uekata, et al. Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model. Br J Pharmacol. 2009;157:1250–62.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol. 2007;571:231–9.PubMedCrossRef Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol. 2007;571:231–9.PubMedCrossRef
41.
Zurück zum Zitat Creasey AA, Chang AC, Feigen L, Wün TC, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest. 1993;91:2850–60.PubMedPubMedCentralCrossRef Creasey AA, Chang AC, Feigen L, Wün TC, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest. 1993;91:2850–60.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez A, et al. Efficacy and safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003;290:238–47.PubMedCrossRef Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez A, et al. Efficacy and safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003;290:238–47.PubMedCrossRef
43.
Zurück zum Zitat Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662–4.PubMedCrossRef Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662–4.PubMedCrossRef
44.
Zurück zum Zitat Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992;89:1551–7.PubMedPubMedCentralCrossRef Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992;89:1551–7.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Taylor Jr FB. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Crit Care Med. 2001;29(7 Suppl):S78–89.PubMedCrossRef Taylor Jr FB. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Crit Care Med. 2001;29(7 Suppl):S78–89.PubMedCrossRef
46.
47.
Zurück zum Zitat Taylor Jr FB, Emerson Jr TE, Jordan R, Chang AK, Blick KE. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock. 1988;26:227–35.PubMed Taylor Jr FB, Emerson Jr TE, Jordan R, Chang AK, Blick KE. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock. 1988;26:227–35.PubMed
48.
Zurück zum Zitat Taylor Jr FB, Chang A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987;79:918–25.PubMedPubMedCentralCrossRef Taylor Jr FB, Chang A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987;79:918–25.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.PubMedCrossRef Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.PubMedCrossRef
51.
Zurück zum Zitat Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res. 1980;29:189–201.PubMedCrossRef Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res. 1980;29:189–201.PubMedCrossRef
52.
Zurück zum Zitat Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock. 1998;9:1–11.PubMedCrossRef Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock. 1998;9:1–11.PubMedCrossRef
53.
Zurück zum Zitat Martineau L, Shek PN. A sustained release bacterial inoculum infusion model of intra-abdominal infection in conscious rats: bacteriology, metabolism, and histopathology. Shock. 1996;5:446–54.PubMedCrossRef Martineau L, Shek PN. A sustained release bacterial inoculum infusion model of intra-abdominal infection in conscious rats: bacteriology, metabolism, and histopathology. Shock. 1996;5:446–54.PubMedCrossRef
54.
Zurück zum Zitat Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun. 1993;61:2741–7.PubMedPubMedCentral Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun. 1993;61:2741–7.PubMedPubMedCentral
55.
Zurück zum Zitat van Zoelen MA, Achouiti A, Schmidt AM, Yang H, Florquin S, Tracey KJ, et al. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis. Crit Care Med. 2010;38:1414–22.PubMedPubMedCentralCrossRef van Zoelen MA, Achouiti A, Schmidt AM, Yang H, Florquin S, Tracey KJ, et al. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis. Crit Care Med. 2010;38:1414–22.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Parker SJ, Watkins PE. Experimental models of gram-negative sepsis. Br J Surg. 2001;88:22–30.PubMedCrossRef Parker SJ, Watkins PE. Experimental models of gram-negative sepsis. Br J Surg. 2001;88:22–30.PubMedCrossRef
57.
Zurück zum Zitat Sacks H, Chalmers TC, Smith H. Randomized versus historical controls for clinical trials. Am J Med. 1982;72:233–40.PubMedCrossRef Sacks H, Chalmers TC, Smith H. Randomized versus historical controls for clinical trials. Am J Med. 1982;72:233–40.PubMedCrossRef
58.
Zurück zum Zitat Piper RD, Cook DJ, Bone RC, Sibbald WJ. Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med. 1996;24:2059–70.PubMedCrossRef Piper RD, Cook DJ, Bone RC, Sibbald WJ. Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med. 1996;24:2059–70.PubMedCrossRef
59.
Zurück zum Zitat Ayala A, Song GY, Chung CS, Redmond KM, Chaudry IH. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med. 2000;28:2949–55.PubMedCrossRef Ayala A, Song GY, Chung CS, Redmond KM, Chaudry IH. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med. 2000;28:2949–55.PubMedCrossRef
60.
Zurück zum Zitat Remick DG, Bolgos G, Copeland S, Siddiqui J. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun. 2005;73:2751–7.PubMedPubMedCentralCrossRef Remick DG, Bolgos G, Copeland S, Siddiqui J. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun. 2005;73:2751–7.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Maier S, Traeger T, Entleutner M, Westerholt A, Kleist B, Hüser N, et al. Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis. Shock. 2004;21:505–11.PubMedCrossRef Maier S, Traeger T, Entleutner M, Westerholt A, Kleist B, Hüser N, et al. Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis. Shock. 2004;21:505–11.PubMedCrossRef
62.
Zurück zum Zitat Wang P, Chaudry IH. A single hit model of polymicrobial sepsis: cecal ligation and puncture. Sepsis. 1998;2:227–33.CrossRef Wang P, Chaudry IH. A single hit model of polymicrobial sepsis: cecal ligation and puncture. Sepsis. 1998;2:227–33.CrossRef
63.
Zurück zum Zitat Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A. 2002;99:12351–6.PubMedPubMedCentralCrossRef Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A. 2002;99:12351–6.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Doerschug K, Powers L, Monick M, Thorne P, Hunninghake G. Antibiotics delay but do not prevent bacteremia and lung injury in murine sepsis. Crit Care Med. 2004;32:489–94.PubMedCrossRef Doerschug K, Powers L, Monick M, Thorne P, Hunninghake G. Antibiotics delay but do not prevent bacteremia and lung injury in murine sepsis. Crit Care Med. 2004;32:489–94.PubMedCrossRef
65.
Zurück zum Zitat Ayala A, Chaudry IH. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock. 1996;6 Suppl 1:S27–38.PubMedCrossRef Ayala A, Chaudry IH. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock. 1996;6 Suppl 1:S27–38.PubMedCrossRef
66.
Zurück zum Zitat Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007;81:137–43.PubMedCrossRef Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007;81:137–43.PubMedCrossRef
67.
Zurück zum Zitat Echtenacher B, Falk W, Männel DN, Krammer PH. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol. 1990;145:3762–6.PubMed Echtenacher B, Falk W, Männel DN, Krammer PH. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol. 1990;145:3762–6.PubMed
68.
Zurück zum Zitat Turnbull IR, Javadi P, Buchman TG, Hotchkiss RS, Karl IE, Coopersmith CM. Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock. 2004;21:121–5.PubMedCrossRef Turnbull IR, Javadi P, Buchman TG, Hotchkiss RS, Karl IE, Coopersmith CM. Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock. 2004;21:121–5.PubMedCrossRef
69.
Zurück zum Zitat Riedemann NC, Neff TA, Guo R-FF, Bernacki KD, Laudes IJ, Sarma JV, et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2003;170:503–7.PubMedCrossRef Riedemann NC, Neff TA, Guo R-FF, Bernacki KD, Laudes IJ, Sarma JV, et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2003;170:503–7.PubMedCrossRef
70.
Zurück zum Zitat Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, et al. Protective effects of C5a blockade in sepsis. Nat Med. 1999;5:788–92.PubMedCrossRef Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, et al. Protective effects of C5a blockade in sepsis. Nat Med. 1999;5:788–92.PubMedCrossRef
71.
Zurück zum Zitat Huber-Lang M, Sarma VJ, Lu KT, McGuire SR, Padgaonkar VA, Guo RF, et al. Role of C5a in multiorgan failure during sepsis. J Immunol. 2001;166:1193–9.PubMedCrossRef Huber-Lang M, Sarma VJ, Lu KT, McGuire SR, Padgaonkar VA, Guo RF, et al. Role of C5a in multiorgan failure during sepsis. J Immunol. 2001;166:1193–9.PubMedCrossRef
72.
Zurück zum Zitat Ward PA. Role of C5 activation products in sepsis. Sci World J. 2010;10:2395–402.CrossRef Ward PA. Role of C5 activation products in sepsis. Sci World J. 2010;10:2395–402.CrossRef
73.
Zurück zum Zitat Flierl MA, Schreiber H, Huber-Lang MS. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome. J Invest Surg. 2006;19:255–65.PubMedCrossRef Flierl MA, Schreiber H, Huber-Lang MS. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome. J Invest Surg. 2006;19:255–65.PubMedCrossRef
74.
Zurück zum Zitat Riedemann N, Guo RF, Hollmann T, Gao H, Neff T, Reuben J, et al. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 2004;18:370–2.PubMed Riedemann N, Guo RF, Hollmann T, Gao H, Neff T, Reuben J, et al. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 2004;18:370–2.PubMed
75.••
Zurück zum Zitat Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol. 1992;148:2724–30. This study showed that blocking TNF-α using anti-TNF antibody in either the CLP model of sepsis or LPS model reduced the TNF-α levels but could not reduce the mortality. This study reiterated the fact that sepsis involves a plethora of complex mechanisms and treatment cannot just focus on targeting a single factor like TNF-α. PubMed Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol. 1992;148:2724–30. This study showed that blocking TNF-α using anti-TNF antibody in either the CLP model of sepsis or LPS model reduced the TNF-α levels but could not reduce the mortality. This study reiterated the fact that sepsis involves a plethora of complex mechanisms and treatment cannot just focus on targeting a single factor like TNF-α. PubMed
76.
Zurück zum Zitat Echtenacher B, Freudenberg MA, Jack RS, Männel DN. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun. 2001;69:7271–6.PubMedPubMedCentralCrossRef Echtenacher B, Freudenberg MA, Jack RS, Männel DN. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun. 2001;69:7271–6.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Moreno SE, Alves-Filho JC, Alfaya TM, da Silva JS, Ferreira SH, Liew FY. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J Immunol. 2006;177:3218–24.PubMedCrossRef Moreno SE, Alves-Filho JC, Alfaya TM, da Silva JS, Ferreira SH, Liew FY. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J Immunol. 2006;177:3218–24.PubMedCrossRef
78.
Zurück zum Zitat Singleton KD, Wischmeyer PE. Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res. 2003;35:486–91.PubMedCrossRef Singleton KD, Wischmeyer PE. Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res. 2003;35:486–91.PubMedCrossRef
79.
Zurück zum Zitat Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94:331–5.PubMed Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94:331–5.PubMed
80.
Zurück zum Zitat Murphey ED. CLP-induced impairment of innate immune function is caused by exposure to the cecal lumenal contents and not the tissue trauma or tissue ischemia/necrosis components. Microbes Infect. 2012;14:35–42.PubMedCrossRef Murphey ED. CLP-induced impairment of innate immune function is caused by exposure to the cecal lumenal contents and not the tissue trauma or tissue ischemia/necrosis components. Microbes Infect. 2012;14:35–42.PubMedCrossRef
81.
Zurück zum Zitat Miyaji T, Hu X, Yuen P, Muramatsu Y, Iyer S, Hewitt S, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 2003;64:1620–31.PubMedCrossRef Miyaji T, Hu X, Yuen P, Muramatsu Y, Iyer S, Hewitt S, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 2003;64:1620–31.PubMedCrossRef
82.
Zurück zum Zitat Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun. 1998;66:2300–9.PubMedPubMedCentral Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun. 1998;66:2300–9.PubMedPubMedCentral
83.
Zurück zum Zitat Traeger T, Koerner P, Kessler W, Cziupka K, Diedrich S, Busemann A, et al. Colon Ascendens Stent Peritonitis (CASP)—a standardized model for polymicrobial abdominal sepsis. J Vis Exp. 2010; 46. Traeger T, Koerner P, Kessler W, Cziupka K, Diedrich S, Busemann A, et al. Colon Ascendens Stent Peritonitis (CASP)—a standardized model for polymicrobial abdominal sepsis. J Vis Exp. 2010; 46.
84.
Zurück zum Zitat Neumann B, Zantl N, Veihelmann A, Emmanuilidis K, Pfeffer K, Heidecke CD, et al. Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int Immunol. 1999;11:217–27.PubMedCrossRef Neumann B, Zantl N, Veihelmann A, Emmanuilidis K, Pfeffer K, Heidecke CD, et al. Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int Immunol. 1999;11:217–27.PubMedCrossRef
85.
Zurück zum Zitat Maier S, Emmanuilidis K, Entleutner M, Zantl N, Werner M, Pfeffer K, et al. Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock. 2000;14:187–92.PubMedCrossRef Maier S, Emmanuilidis K, Entleutner M, Zantl N, Werner M, Pfeffer K, et al. Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock. 2000;14:187–92.PubMedCrossRef
86.
Zurück zum Zitat Barthlen W, Zantl N, Pfeffer K, Heidecke CD, Holzmann B, Stadler J. Impact of experimental peritonitis on bone marrow cell function. Surgery. 1999;126:41–7.PubMedCrossRef Barthlen W, Zantl N, Pfeffer K, Heidecke CD, Holzmann B, Stadler J. Impact of experimental peritonitis on bone marrow cell function. Surgery. 1999;126:41–7.PubMedCrossRef
87.
Zurück zum Zitat Emmanuilidis K, Weighardt H, Maier S, Gerauer K, Fleischmann T, Zheng XX, et al. Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol. 2001;167:3919–27.PubMedCrossRef Emmanuilidis K, Weighardt H, Maier S, Gerauer K, Fleischmann T, Zheng XX, et al. Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol. 2001;167:3919–27.PubMedCrossRef
88.
Zurück zum Zitat Hammer M, Echtenachter B, Weighardt H, Jozefowski K, Rose-John S, Männel DN, et al. Increased inflammation and lethality of Dusp1−/− mice in polymicrobial peritonitis models. Immunology. 2010;131:395–404.PubMedPubMedCentralCrossRef Hammer M, Echtenachter B, Weighardt H, Jozefowski K, Rose-John S, Männel DN, et al. Increased inflammation and lethality of Dusp1−/− mice in polymicrobial peritonitis models. Immunology. 2010;131:395–404.PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Entleutner M, Traeger T, Westerholt A, Holzmann B, Stier A, Pfeffer K, et al. Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis. Int J Colorectal Dis. 2006;21:64–70.PubMedCrossRef Entleutner M, Traeger T, Westerholt A, Holzmann B, Stier A, Pfeffer K, et al. Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis. Int J Colorectal Dis. 2006;21:64–70.PubMedCrossRef
90.
Zurück zum Zitat Weighardt H, Kaiser-Moore S, Vabulas RM, Kirschning CJ, Wagner H, Holzmann B. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol. 2002;169:2823–7.PubMedCrossRef Weighardt H, Kaiser-Moore S, Vabulas RM, Kirschning CJ, Wagner H, Holzmann B. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol. 2002;169:2823–7.PubMedCrossRef
91.
Zurück zum Zitat Daubeuf B, Mathison J, Spiller S, Hugues S, Herren S, Ferlin W, et al. TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol. 2007;179:6107–14.PubMedCrossRef Daubeuf B, Mathison J, Spiller S, Hugues S, Herren S, Ferlin W, et al. TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol. 2007;179:6107–14.PubMedCrossRef
92.
Zurück zum Zitat Yuan Y, Ren J, Wu X, Cao S, Li J. Exogenous C3 postpones complement exhaustion and confers organ protection in murine sepsis. J Surg Res. 2011;168:e87–94.PubMedCrossRef Yuan Y, Ren J, Wu X, Cao S, Li J. Exogenous C3 postpones complement exhaustion and confers organ protection in murine sepsis. J Surg Res. 2011;168:e87–94.PubMedCrossRef
93.
Zurück zum Zitat Kerschen EJ, Fernandez JA, Cooley BC, Yang XV, Sood R, Mosnier LO, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204:2439–48.PubMedPubMedCentralCrossRef Kerschen EJ, Fernandez JA, Cooley BC, Yang XV, Sood R, Mosnier LO, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204:2439–48.PubMedPubMedCentralCrossRef
94.
Zurück zum Zitat Feterowski C, Mack M, Weighardt H, Bartsch B, Kaiser-Moore S, Holzmann B. CC chemokine receptor 2 regulates leukocyte recruitment and IL-10 production during acute polymicrobial sepsis. Eur J Immunol. 2004;34:3664–73.PubMedCrossRef Feterowski C, Mack M, Weighardt H, Bartsch B, Kaiser-Moore S, Holzmann B. CC chemokine receptor 2 regulates leukocyte recruitment and IL-10 production during acute polymicrobial sepsis. Eur J Immunol. 2004;34:3664–73.PubMedCrossRef
95.
Zurück zum Zitat Schabbauer G. Polymicrobial sepsis models: CLP versus CASP. Drug Discov Today Dis Models. 2012;9:e17–21.CrossRef Schabbauer G. Polymicrobial sepsis models: CLP versus CASP. Drug Discov Today Dis Models. 2012;9:e17–21.CrossRef
96.
Zurück zum Zitat Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest. 1986;78:259–70.PubMedPubMedCentralCrossRef Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest. 1986;78:259–70.PubMedPubMedCentralCrossRef
97.
Zurück zum Zitat Ahrenholz DH, Simmons RL. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery. 1980;88:41–7.PubMed Ahrenholz DH, Simmons RL. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery. 1980;88:41–7.PubMed
98.••
Zurück zum Zitat Mathiak G, Szewczyk D, Abdullah F, Ovadia P, Feuerstein G, Rabinovici R. An improved clinically relevant sepsis model in the conscious rat. Crit Care Med. 2000;28:1947–52. This study developed a more clinically relevant model of sepsis by intraperitoneal implantation of fibrin clot containing E coli. It resembled human sepsis by showing thrombocytopenia, leukopenia, elevated cardiac index and fluctuating stroke volume index and peripheral resistance index. PubMedCrossRef Mathiak G, Szewczyk D, Abdullah F, Ovadia P, Feuerstein G, Rabinovici R. An improved clinically relevant sepsis model in the conscious rat. Crit Care Med. 2000;28:1947–52. This study developed a more clinically relevant model of sepsis by intraperitoneal implantation of fibrin clot containing E coli. It resembled human sepsis by showing thrombocytopenia, leukopenia, elevated cardiac index and fluctuating stroke volume index and peripheral resistance index. PubMedCrossRef
99.
Zurück zum Zitat Fink MP, MacVittie TJ, Casey LC. Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg. 1984;200:619–26.PubMedPubMedCentralCrossRef Fink MP, MacVittie TJ, Casey LC. Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg. 1984;200:619–26.PubMedPubMedCentralCrossRef
100.
Zurück zum Zitat Knapp S, Schultz MJ, van der Poll T. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock. 2005;24 Suppl 1:12–8.PubMedCrossRef Knapp S, Schultz MJ, van der Poll T. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock. 2005;24 Suppl 1:12–8.PubMedCrossRef
101.
Zurück zum Zitat Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ, et al. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun. 1996;64:5211–8.PubMedPubMedCentral Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ, et al. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun. 1996;64:5211–8.PubMedPubMedCentral
102.
Zurück zum Zitat van der Poll T, Keogh CV, Buurman WA, Lowry SF. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 1997;155:603–8.PubMedCrossRef van der Poll T, Keogh CV, Buurman WA, Lowry SF. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 1997;155:603–8.PubMedCrossRef
103.
Zurück zum Zitat Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol. 1995;155:722–9.PubMed Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol. 1995;155:722–9.PubMed
104.
Zurück zum Zitat van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996;174:994–1000.PubMedCrossRef van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996;174:994–1000.PubMedCrossRef
105.
Zurück zum Zitat Pène F, Ait-Oufella H, Taccone FS, Monneret G, Sharshar T, Tamion F, et al. Insights and limits of translational research in critical care medicine. Ann Intensive Care. 2015;5:8.PubMedPubMedCentralCrossRef Pène F, Ait-Oufella H, Taccone FS, Monneret G, Sharshar T, Tamion F, et al. Insights and limits of translational research in critical care medicine. Ann Intensive Care. 2015;5:8.PubMedPubMedCentralCrossRef
106.
Zurück zum Zitat Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med. 2009;37:S30–7.PubMedCrossRef Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med. 2009;37:S30–7.PubMedCrossRef
107.
Zurück zum Zitat Shukla P, Rao M, Pandey G, Sharma S, Mittapelly N, Shegokar R, et al. Therapeutic interventions in sepsis: current and anticipated pharmacological agents. Br J Pharmacol. 2014;171:5011–31.PubMedPubMedCentral Shukla P, Rao M, Pandey G, Sharma S, Mittapelly N, Shegokar R, et al. Therapeutic interventions in sepsis: current and anticipated pharmacological agents. Br J Pharmacol. 2014;171:5011–31.PubMedPubMedCentral
108.
Zurück zum Zitat Unsinger J, McDonough JS, Shultz LD, Ferguson TA, Hotchkiss RS. Sepsis-induced human lymphocyte apoptosis and cytokine production in “humanized” mice. J Leukoc Biol. 2009;86:219–27.PubMedPubMedCentralCrossRef Unsinger J, McDonough JS, Shultz LD, Ferguson TA, Hotchkiss RS. Sepsis-induced human lymphocyte apoptosis and cytokine production in “humanized” mice. J Leukoc Biol. 2009;86:219–27.PubMedPubMedCentralCrossRef
109.
Zurück zum Zitat Jain V, Shukla P, Pal R, Mishra PR. Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis. Pharm Res. 2014;31:2630–42.PubMedCrossRef Jain V, Shukla P, Pal R, Mishra PR. Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis. Pharm Res. 2014;31:2630–42.PubMedCrossRef
110.
Zurück zum Zitat Stefan M, Melnig V, Pricop D, Neagu A, Mihasan M, Tartau L, et al. Attenuated effects of chitosan-capped gold nanoparticles on LPS-induced toxicity in laboratory rats. Mater Sci Eng C. 2013;33:550–6.CrossRef Stefan M, Melnig V, Pricop D, Neagu A, Mihasan M, Tartau L, et al. Attenuated effects of chitosan-capped gold nanoparticles on LPS-induced toxicity in laboratory rats. Mater Sci Eng C. 2013;33:550–6.CrossRef
111.
Zurück zum Zitat Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood. Am J Physiol Lung Cell Mol Physiol. 2012;302:L1003–13.PubMedPubMedCentralCrossRef Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood. Am J Physiol Lung Cell Mol Physiol. 2012;302:L1003–13.PubMedPubMedCentralCrossRef
112.
Zurück zum Zitat Fry DE. The importance of antibiotic pharmacokinetics in critical illness. Am J Surg. 1996;172:20S–5.PubMedCrossRef Fry DE. The importance of antibiotic pharmacokinetics in critical illness. Am J Surg. 1996;172:20S–5.PubMedCrossRef
Metadaten
Titel
Differential Paradigms in Animal Models of Sepsis
verfasst von
S. Manoj Kumar Kingsley
B. Vishnu Bhat
Publikationsdatum
01.09.2016
Verlag
Springer US
Erschienen in
Current Infectious Disease Reports / Ausgabe 9/2016
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-016-0535-8

Weitere Artikel der Ausgabe 9/2016

Current Infectious Disease Reports 9/2016 Zur Ausgabe

Skin, Soft Tissue, Bone and Joint Infectious Diseases (N Safdar, Section Editor)

Cutaneous Manifestations of Selected Parasitic Infections in Western Pacific and Southeast Asian Regions

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

The Traveling Microbiome

Tropical, Travel and Emerging Infections (L Chen, Section Editors)

Cutaneous Myiasis

Pediatric Infectious Diseases (I Brook, Section Editor)

Cryptococcal Disease in HIV-Infected Children

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.